A big contract award created a surge in a medical tech stock Monday. Here’s some small stocks making big moves on Monday, May 7, 2018 (as of 4 pm EST):
Covalon Technologies Ltd. (TSXV:COV), a medical tech stock, powered 53% higher to $5.63 on Monday after announcing that it has won a series of competitive contracts in the Middle East with an estimated sales value of $100 million over a three-year period.
As well, shares of Metals Creek Resources Corp. (TSXV:MEK) slipped 8% to $0.055 as the junior explorer said results have been received from the first four of a nine-hole diamond drill program designed to further test multiple targets on the Ogden Gold Project south of Timmins, Ontario, which included 1.42 g/t gold over 6.0 metres.
East Africa Metals Inc. (TSXV:EAM), meanwhile, reported that it will continue to explore highly prospective areas in the immediate vicinity of the known Terakimti Gold, Mato Bula Gold Copper, and Da Tambuk Gold deposit areas in Ethiopia through further targeted and staged exploration. East Africa Metals stock moved up 20% to $0.245 following the announcement.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
Covalon Technologies Ltd. (TSXV:COV), a medical tech stock, powered 53% higher to $5.63 on Monday after announcing that it has won a series of competitive contracts in the Middle East with an estimated sales value of $100 million over a three-year period.
